Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.41 Analyst target: $10.00 Upside: 2316.63%
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, is focused on translating medical advances in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company is headquartered in Worcester, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.